Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CFSAN Constituent Updates

CFSAN Constituent Updates Home
          Food
          News & Events from CFSAN
          CFSAN Constituent Updates
          FDA Extends Comment Period for Third Installment of the Draft Guidance for the Intentional Adulteration RuleCFSAN Constituent Updates FDA Extends Comment Period for Third Installment of the Draft Guidance for the Intentional Adulteration Rule
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintConstituent Update

May 27, 2020

The U.S. Food and Drug Administration is extending the comment period for the third installment of the draft guidance designed to support compliance with the Mitigation Strategies to Protect Food Against Intentional Adulteration (IA) rule under the FDA Food Safety Modernization Act (FSMA).

The Agency released the third installment of the draft guidance in February 2020. Since that time, FDA has received a request for extension to allow stakeholders sufficient time to provide comprehensive feedback. The comment period will be extended until August 14, 2020.

This last installment of the IA rule draft guidance adds to the previously published revised draft guidance. Chapters in the last installment cover topics focusing on food defense corrective actions, food defense verification, reanalysis of food defense plans, and recordkeeping; it also includes appendices on FDA’s online Mitigation Strategies Database and how a business can determine if it is a small or very small business under the rule.

Comments can be submitted electronically via Regulations.gov to docket FDA-2018-D-1398.

**For More Information**

Draft Guidance for Industry: Mitigation Strategies to Protect Food Against Intentional Adulteration
	Supplemental Draft Guidance for Industry: Mitigation Strategies to Protect Food Against Intentional Adulteration
	Food Defense Plan Builder (Version 2.0)
	Food Safety Preventive Controls Alliance (FSPCA) Training Materials and Courses

                                                                                  Content current as of:
      05/27/2020
              
              
Regulated Product(s)
		 Food & BeveragesCFSAN Constituent Updates
 Subscribe to CFSAN Constituent Updates
                        Get email updates delivered to your inbox.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop